Macrogenics (MGNX) Share-based Compensation (2012 - 2026)

Macrogenics (MGNX) has 15 years of Share-based Compensation data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Share-based Compensation fell 39.67% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was -$1.5 million, a 104.62% decrease from a year earlier, with the FY2025 full-year figure at $288000.0, down 99.02% from the prior year.
• Share-based Compensation for Q1 2026 stood at $2.6 million, up from -$11.3 million in the prior quarter.
• Over the last five years, Share-based Compensation for MGNX reached as high as $15.7 million in Q3 2022 and fell as low as -$11.3 million in Q4 2025.
• Historically, Share-based Compensation has averaged $4.7 million across 5 years, with a median of $4.7 million in 2022.
• Across the five-year window, Share-based Compensation soared 1413.29% in 2024 and sank 200.64% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $4.7 million in 2022, then decreased by 8.06% to $4.4 million in 2023, then soared by 158.43% to $11.3 million in 2024, then sank by 200.64% to -$11.3 million in 2025, then surged by 123.34% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $2.6 million in Q1 2026, -$11.3 million in Q4 2025, and $11.3 million in Q3 2025.